Natalia Presa

Ms. Natalia Presa


Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 February 2026
Verified
Book Chapter
Open access
PDF file
AGAna Gomez
Ana Gomez
PGPatricia Gangoiti
Patricia Gangoiti
LCLaura Camacho
Laura Camacho
NPNatalia Presa
Natalia Presa
CMCesar Martin
Cesar Martin
Antonio Gomez-MunozAntonio Gomez-Munoz
Antonio Gomez-Munoz
Lung cancer is one of the most lethal types of cancer, being responsible for the majority of cancer-associated deaths worldwide. The main therapeutic strategy for the treatment of lung cancer is chemotherapy, but the currently available drugs are not sufficiently effective to overcome the disease. In the present chapter, we show that extracellular phosphatidic acid (PA), a bioactive phospholipid involved in inflammatory responses and cell proliferation, induces rapid phosphorylation of AKT and mammalian target of rapamycin (mTOR), and that pretreatment of the cells with LY294002, 10-DEBC, or rapamycin, which specifically inhibit phosphatidylinositol 3-kinase (PI3K), AKT, or mTOR, respectively, blocks PA-stimulated lung cancer cell migration. Additionally, AM966 and Ki16425, which inhibit lysophosphatidic acid receptor 1 (LPAR1), completely block PA-stimulated phosphorylation of mTOR and lung cancer cell migration, suggesting that stimulation of chemotaxis by PA involves its interaction with LPA receptors. Moreover, exogenous PA induced phosphorylation of focal adhesion kinase (FAK), which is upstream of Rac1 activation, and inhibition of FAK or Rac1 also blocked PA-stimulated lung cancer cell migration. It can be concluded that the PA-LPA1-PI3K-AKT-mTOR pathway and the FAK/Rac1 axis are highly relevant factors for regulation of lung cancer cell migration, and that inhibition of PA generation may be of crucial importance for reducing lung cancer dissemination.

Verified
Journal Article
Open access
PDF file
JRJuanma Ramirez
Juanma Ramirez
GPGorka Prieto
Gorka Prieto
EBErik P. Barrio
Erik P. Barrio
AAAinhoa Atxa-Espiga
Ainhoa Atxa-Espiga
NPNatalia Presa
Natalia Presa
NONerea Osinalde
Nerea Osinalde
Deubiquitinases (DUBs) of the ubiquitin C-terminal hydrolase (UCH) family play critical roles in regulating ubiquitin-dependent signaling, yet their substrate specificity and functional organization remain incompletely defined. Here, we systematically characterized the ubiquitination landscape associated with UCH family members (UCHL1, UCHL3, UCHL5, and BAP1) using a quantitative proteomics workflow combining siRNA-mediated DUB silencing, bioUb-based enrichment of ubiquitinated proteins, and label-free mass spectrometry. Proteins exhibiting increased ubiquitination following DUB depletion were identified as candidate substrates. Our analysis revealed that UCH family members regulate largely distinct subsets of ubiquitinated proteins, with limited overlap in their candidate profiles despite sharing conserved catalytic domains. In parallel, site-resolved ubiquitinomics identified 851 ubiquitination sites, including 106 not previously reported, expanding the current landscape of experimentally validated ubiquitin-modified lysines. Functionally, substrate networks link individual UCH enzymes to distinct yet partially overlapping cellular processes, including hypoxia signaling, RNA metabolism, vesicle trafficking, apoptosis, and chromatin regulation. Notably, known substrates such as HIF-1α validated the approach, while recurrent detection of key regulators, including MCL1, pointed to convergence at the level of apoptosis control. Together, these findings provide a resource for exploring the distinct and potentially overlapping roles of UCH deubiquitinases within cellular ubiquitin-regulatory networks.